EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, CMVLF: Cellectis Romainville

19 Nov 2025
LAST:

4.500

CHANGE:
 0.54		OPEN:
4.500		HIGH:
4.500		ASK:
0.000		VOLUME:
2.0K
CHG(%):
10.71		PREV:
5.040		LOW:
4.500		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

PROFILE

Name:Cellectis Romainville
About:Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing ALLO-501 to treat large B-cell lymphoma; ALLO-316, a gene-edited allogeneic CAR T-cell product targeting CD70; ALLO-819 to treat acute myeloid leukemia; ALLO-213 for the treatment of small cell lung cancer; and ALLO-182 to treat gastric and pancreatic cancer. It also develops UCART22 for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia; UCART123 to treat acute myeloid leukemia; UCART 20x22 for relapsed or refractory B-Cell non-hodgkin's lymphoma; and cema-cel to treat relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. The company was founded in 1999 and is headquartered in Paris, France.
Sector:Healthcare
Industry:Biotechnology
Address:8, rue de la Croix Jarry, Paris, France, 75013
Website:https://www.cellectis.com
CIK:0001627281
FIGI:BBG0016RPHK4

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:3.9015.3%
Week High:4.500.0%
Week Low:4.500.0%